*Please note, this is a temporary position with the potential to convert to a permanent position.
Machine learning integrated with biology at scale lies at the core of insitro’s approach to rethinking drug discovery and development. In this role, you will contribute to the core biology platform that insitro is building by working as a key member of the Process Engineering team. You will be working on many aspects of iPSC technology such as iPSC automation, cell line maintenance, and differentiation. This role will primarily focus on supporting the day-to-day activities for the set up, operations, and teardown of our automated cell line management systems. You will also work with cross-functional teams to identify and develop continuous improvement solutions to improve the reliability and quality of our workflows. You will possess strong interpersonal skills, a strong collaborative work ethic, ability to adapt to changing needs, and the capacity to multitask to meet key goals. Strong communication and adaptability are essential to success in this position. Occasional weekend work will be required.
Nice to Have
insitro is a data-driven drug discovery and development company using machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company is applying state-of-the-art technologies from bioengineering to create massive data sets that enable the power of modern machine learning methods to be brought to bear on key bottlenecks in pharmaceutical R&D. The resulting predictive models are used to accelerate target selection, to design and develop effective therapeutics, and to inform clinical strategy. insitro was launched in 2018 with a Series A of $100M funded by top investors including a16z, Arch Venture Partners, Foresite Capital, GV, and Third Rock Ventures.
The company has announced collaborations with Gilead Sciences in the area of NASH (2019) and Bristol Myers Squibb in the area of ALS (2020) and, in mid 2020, completed a Series B financing of $143M including current investors and new investors Canada Pension Plan Investment Board (CPP Investments), T. Rowe Price, BlackRock, Casdin Capital and other leading investors. The company is located in South San Francisco, CA. For more information about insitro, please visit the company’s website at www.insitro.com
Your application was submitted successfully.